{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:34:46Z","timestamp":1790256886095,"version":"4.1.0"},"reference-count":283,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pnpbp.2015.12.006","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T04:32:03Z","timestamp":1451363523000},"page":"120-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"special_numbering":"C","title":["5-HT2C receptors in psychiatric disorders: A review"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-2453","authenticated-orcid":false,"given":"A.","family":"Chagraoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Thibaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Skiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Thuillez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bourin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2015.12.006_bb0005","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1523\/JNEUROSCI.1090-09.2009","article-title":"PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors","volume":"29","author":"Abbas","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0010","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0028-3908(95)00138-7","article-title":"Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera","volume":"34","author":"Abramowski","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/syn.20109","article-title":"Modulation of dopamine release by striatal 5-HT2C receptors","volume":"55","author":"Alex","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0006-8993(95)00523-S","article-title":"Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims","volume":"688","author":"Arango","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0040","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/11595380-000000000-00000","article-title":"Pharmacogenetics of response to antipsychotics in patients with schizophrenia","volume":"25","author":"Arranz","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0045","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archpsyc.1976.01770100055005","article-title":"5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?","volume":"33","author":"Asberg","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0050","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.cortex.2012.05.022","article-title":"Dorsolateral prefrontal contributions to human working memory","volume":"49","author":"Barbey","year":"2013","journal-title":"Cortex"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000321593","article-title":"Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal\/frontal cortex and hippocampus","volume":"63","author":"Barbon","year":"2011","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/archpsyc.58.3.280","article-title":"Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia","volume":"58","author":"Barch","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0065","doi-asserted-by":"crossref","first-page":"11687","DOI":"10.1016\/S0021-9258(17)32625-X","article-title":"Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands","volume":"269","author":"Barker","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0070","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0075","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1146\/annurev.biochem.71.110601.135501","article-title":"RNA editing by adenosine deaminases that act on RNA","volume":"71","author":"Bass","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0080","article-title":"Role of serotonin in obsessive\u2013compulsive disorder","volume":"13-20","author":"Baumgarten","year":"1998","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0085","doi-asserted-by":"crossref","first-page":"20257","DOI":"10.1074\/jbc.M312106200","article-title":"The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins","volume":"279","author":"Becamel","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0090","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1471-4159.2000.740478.x","article-title":"Structure of the human serotonin 5-HT4 receptor gene and cloning of a novel 5-HT4 splice variant","volume":"74","author":"Bender","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0100","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.bjp.0704255","article-title":"RNA-editing of the 5-HT(2C) receptor alters agonist-receptor\u2013effector coupling specificity","volume":"134","author":"Berg","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tips.2005.10.008","article-title":"Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors","volume":"26","author":"Berg","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0110","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1124\/jpet.107.131524","article-title":"A conservative, single-amino acid substitution in the second cytoplasmic domain of the human serotonin2C receptor alters both ligand-dependent and -independent receptor signaling","volume":"324","author":"Berg","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.kjms.2012.11.003","article-title":"Effects of agomelatine in a murine model of obsessive\u2013compulsive disorder: interaction with meta-chlorophenylpiperazine, bicuculline, and diazepam","volume":"29","author":"Bhutada","year":"2013","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/syn.10116","article-title":"Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study","volume":"46","author":"Blackburn","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0125","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/syn.20263","article-title":"The acute and chronic administration of the 5-HT(2B\/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: an in vivo extracellular single cell study","volume":"59","author":"Blackburn","year":"2006","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-3223(98)00114-0","article-title":"Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive\u2013compulsive disorder responses","volume":"44","author":"Blier","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0135","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0022-3565(25)11657-1","article-title":"Identification and assay of serotonin in brain","volume":"117","author":"Bogdanski","year":"1956","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0140","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004714-199604000-00008","article-title":"ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group","volume":"16","author":"Borison","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1139\/jpn.0414","article-title":"Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors","volume":"29","author":"Bourin","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245227","article-title":"Dopamine and depression","volume":"91","author":"Brown","year":"1993","journal-title":"J. Neural Transm. Gen. Sect."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0155","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuroscience.2006.12.071","article-title":"Distribution of serotonin 5-HT2C receptors in the ventral tegmental area","volume":"146","author":"Bubar","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(90)94100-C","article-title":"Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites","volume":"191","author":"Canton","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0170","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0026-895X(25)09380-0","article-title":"Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing","volume":"50","author":"Canton","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R","article-title":"GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex","volume":"38","author":"Carr","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0180","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0006-3223(03)00526-2","article-title":"Decrease of serotonin receptor 2C in schizophrenia brains identified by high-resolution mRNA expression analysis","volume":"54","author":"Castensson","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000119427","article-title":"Dexamethasone suppression test in patients with primary obsessive\u2013compulsive disorder and in healthy controls","volume":"23","author":"Catapano","year":"1990","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0190","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0091-3057(95)00189-4","article-title":"5-HT1A receptor full and partial agonists and 5-HT2C (but not 5-HT3) receptor antagonists increase rates of punished responding in rats","volume":"52","author":"Cervo","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0195","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.2042-7158.1993.tb05578.x","article-title":"Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice","volume":"45","author":"Cesana","year":"1993","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0200","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2174\/138945006779025400","article-title":"Susceptibility genes for the side effect of antipsychotics on body weight and obesity","volume":"7","author":"Chagnon","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-003-1465-3","article-title":"Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats","volume":"170","author":"Chagraoui","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1154433","article-title":"Orbitofrontal dysfunction in patients with obsessive\u2013compulsive disorder and their unaffected relatives","volume":"321","author":"Chamberlain","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archpsyc.1988.01800260095012","article-title":"Serotonin function in obsessive\u2013compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects","volume":"45","author":"Charney","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0220","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1017\/S1355838200000170","article-title":"A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains","volume":"6","author":"Chen","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0225","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0031-9384(03)00047-7","article-title":"Compulsive behavior in the 5-HT2C receptor knockout mouse","volume":"78","author":"Chou-Green","year":"2003","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0031-9384(03)00096-9","article-title":"Repeated stress in young and old 5-HT(2C) receptor knockout mice","volume":"79","author":"Chou-Green","year":"2003","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0235","first-page":"279","article-title":"Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive\u2013compulsive disorder","volume":"26","author":"Chouinard","year":"1990","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0028-3908(99)00086-6","article-title":"Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS","volume":"39","author":"Clemett","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0924-977X(01)00078-5","article-title":"Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice","volume":"11","author":"Clenet","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0250","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2010.04.008","article-title":"Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design","volume":"127","author":"Coccurello","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0255","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0022-3565(25)39117-2","article-title":"Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors","volume":"242","author":"Conn","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0260","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.npp.1300474","article-title":"Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade","volume":"29","author":"Cremers","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0265","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/sj.npp.1301287","article-title":"Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies","volume":"32","author":"Cremers","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 232","key":"10.1016\/j.pnpbp.2015.12.006_bb0270","first-page":"1","article-title":"Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons","author":"Dahlstroem","year":"1964","journal-title":"Acta Physiol. Scand. Suppl."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0275","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2004.09.006","article-title":"Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates","volume":"28","author":"Dalley","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0280","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1016\/S0021-9258(17)39651-5","article-title":"Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites","volume":"260","author":"de Chaffoy de Courcelles","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0285","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0165-6147(00)01811-3","article-title":"The nigrostriatal dopamine system: a neglected target for 5-HT2C receptors","volume":"22","author":"De Deurwaerdere","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0290","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1523\/JNEUROSCI.0112-04.2004","article-title":"Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens","volume":"24","author":"De Deurwaerdere","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0295","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/npp.2013.313","article-title":"Stimulation of 5-HT2C receptors improves cognitive deficits induced by human tryptophan hydroxylase 2 loss of function mutation","volume":"39","author":"Del'Guidice","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0300","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S1355617706060322","article-title":"Is the prefrontal cortex necessary for delay task performance? Evidence from lesion and FMRI data","volume":"12","author":"D'Esposito","year":"2006","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0305","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0306-4522(98)00655-1","article-title":"Selective blockade of serotonin-2C\/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study","volume":"91","author":"Di Giovanni","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2","article-title":"Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C\/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study","volume":"35","author":"Di Giovanni","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0315","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0306-4522(00)00561-3","article-title":"m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors","volume":"103","author":"Di Giovanni","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0320","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2174\/156802606778522113","article-title":"Central serotonin2C receptor: from physiology to pathology","volume":"6","author":"Di Giovanni","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0325","first-page":"ix","article-title":"Serotonin\u2013dopamine interaction: experimental evidence and therapeutic relevance. Preface","volume":"172","author":"Di Giovanni","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0330","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0028-3908(99)00047-7","article-title":"SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system","volume":"38","author":"Di Matteo","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0006-8993(00)02246-0","article-title":"Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors","volume":"865","author":"Di Matteo","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s002130000420","article-title":"Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors","volume":"150","author":"Di Matteo","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0345","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(00)02062-X","article-title":"Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area","volume":"864","author":"Doherty","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0350","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1046\/j.1471-4159.2003.02115.x","article-title":"RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia","volume":"87","author":"Dracheva","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0355","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ajmg.b.30864","article-title":"Focus on HTR2C: a possible suggestion for genetic studies of complex disorders","volume":"150B","author":"Drago","year":"2009","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0360","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pnpbp.2003.09.030","article-title":"The serotonin\u2013dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression","volume":"28","author":"Dremencov","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0365","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuropharm.2004.09.013","article-title":"Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment","volume":"48","author":"Dremencov","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0370","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/138945006775515491","article-title":"Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response","volume":"7","author":"Dremencov","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0375","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1124\/jpet.104.075382","article-title":"WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indol e], a novel 5-hydroxytryptamine 2C receptor\u2013selective agonist with anorectic activity","volume":"313","author":"Dunlop","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0380","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2","article-title":"Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats","volume":"384","author":"Eberle-Wang","year":"1997","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0385","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1248\/bpb.35.376","article-title":"Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice","volume":"35","author":"Egashira","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0390","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0165-6147(97)01043-2","article-title":"The 5-HT7 receptor: orphan found","volume":"18","author":"Eglen","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0395","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00004714-200212000-00014","article-title":"5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia","volume":"22","author":"Ellingrod","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0400","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.psychres.2009.04.009","article-title":"Circadian misalignment in major depressive disorder","volume":"168","author":"Emens","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0405","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1017\/S0033291799002822","article-title":"Impulsiveness, serotonin genes and repetition of deliberate self-harm (DSH)","volume":"30","author":"Evans","year":"2000","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0410","article-title":"Revisiting the serotonin hypothesis: implications for major depressive disorders","author":"Fakhoury","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0415","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1988.01800250087012","article-title":"Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs","volume":"45","author":"Farde","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"Suppl","key":"10.1016\/j.pnpbp.2015.12.006_bb0420","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1007\/BF00442555","article-title":"D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics","volume":"99","author":"Farde","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0425","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0430","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1038\/sj.npp.1395328","article-title":"Messenger RNA editing of the human serotonin 5-HT2C receptor","volume":"21","author":"Fitzgerald","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0435","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/BF02246645","article-title":"Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation","volume":"123","author":"Fone","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0440","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0893-133X(02)00353-6","article-title":"Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor","volume":"27","author":"Frank","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0445","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0031-9384(98)00096-1","article-title":"Medial prefrontal lesion deficits involving or sparing the prelimbic area in the rat","volume":"64","author":"Fritts","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0450","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003495-199753020-00007","article-title":"Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses","volume":"53","author":"Fulton","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0455","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/j.1460-2075.1995.tb07280.x","article-title":"The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants","volume":"14","author":"Gerald","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0460","first-page":"117","article-title":"Aggressive behavior: theoretical and biological aspects","volume":"24","author":"Giotakos","year":"2013","journal-title":"Psychiatriki"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0465","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D","article-title":"Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat","volume":"36","author":"Gobert","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0470","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/tpj.2009.18","article-title":"Olanzapine-induced weight gain is associated with the -759C\/T and -697G\/C polymorphisms of the HTR2C gene","volume":"9","author":"Godlewska","year":"2009","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0475","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1037\/h0031649","article-title":"Analysis of the delayed-alternation deficit produced by dorsolateral prefrontal lesions in the rhesus monkey","volume":"77","author":"Goldman","year":"1971","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0480","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archpsyc.1989.01810010038006","article-title":"Efficacy of fluvoxamine in obsessive\u2013compulsive disorder. A double-blind comparison with placebo","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0485","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archpsyc.1990.01810180077011","article-title":"Specificity of serotonin reuptake inhibitors in the treatment of obsessive\u2013compulsive disorder. Comparison of fluvoxamine and desipramine","volume":"47","author":"Goodman","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0490","first-page":"1277","article-title":"Presence of a 5-HT7 receptor positively coupled to adenylate cyclase activation in human granulosa-lutein cells","volume":"85","author":"Graveleau","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0495","first-page":"246","article-title":"The effects of electroconvulsive therapy and antidepressant drugs on monoamine receptors in rodent brain\u2014similarities and differences","volume":"123","author":"Green","year":"1986","journal-title":"CIBA Found. Symp."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0500","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0163-7258(95)98597-J","article-title":"5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30years of research","volume":"65","author":"Griebel","year":"1995","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0505","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/PL00005318","article-title":"Differences in agonist-independent activity of 5-Ht2A and 5-HT2c receptors revealed by heterologous expression","volume":"359","author":"Grotewiel","year":"1999","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0510","article-title":"Agomelatine versus other antidepressive agents for major depression","volume":"12","author":"Guaiana","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0515","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1523\/JNEUROSCI.22-24-10529.2002","article-title":"Modulation of serotonin 2C receptor editing by sustained changes in serotonergic neurotransmission","volume":"22","author":"Gurevich","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0520","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0896-6273(02)00660-8","article-title":"Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims","volume":"34","author":"Gurevich","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0525","first-page":"54","article-title":"Neuroleptic malignant syndrome, with attention to its occurrence with atypical antipsychotic medication: a review","volume":"20","author":"Guzofski","year":"2006","journal-title":"Eff. J. Psych."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0530","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1097\/CCM.0b013e318180266e","article-title":"Hypercapnic acidosis attenuates the pulmonary innate immune response in ventilated healthy mice","volume":"36","author":"Halbertsma","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0535","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00004714-199604000-00011","article-title":"Serotonin, psilocybin, and body dysmorphic disorder: a case report","volume":"16","author":"Hanes","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0540","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecular biology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0545","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0026-895X(25)09859-1","article-title":"Ca2+ permeability of cloned and native 5-hydroxytryptamine type 3 receptors","volume":"46","author":"Hargreaves","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0550","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00213-004-2019-z","article-title":"Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats","volume":"178","author":"Hayashi","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0555","doi-asserted-by":"crossref","first-page":"15049","DOI":"10.1073\/pnas.95.25.15049","article-title":"Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice","volume":"95","author":"Heisler","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0560","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1749-6632.2003.tb03177.x","article-title":"Central serotonin and melanocortin pathways regulating energy homeostasis","volume":"994","author":"Heisler","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0565","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1601-183X.2007.00316.x","article-title":"Serotonin 5-HT(2C) receptors regulate anxiety-like behavior","volume":"6","author":"Heisler","year":"2007","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0570","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(24)38891-3","article-title":"Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors","volume":"295","author":"Herrick-Davis","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0575","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/mol.114.096636","article-title":"Native serotonin 5-HT2C receptors are expressed as homodimers on the apical surface of choroid plexus epithelial cells","volume":"87","author":"Herrick-Davis","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0580","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0091-3057(01)00709-2","article-title":"Serotonin 2C receptor agonists and the behavioural satiety sequence in mice","volume":"71","author":"Hewitt","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0585","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0006-3223(97)00458-7","article-title":"Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive\u2013compulsive disorder and controls","volume":"44","author":"Ho Pian","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0590","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archpsyc.57.1.76","article-title":"Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive\u2013compulsive and major depressive disorders","volume":"57","author":"Hoehn-Saric","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0595","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0014-5793(89)81390-0","article-title":"Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain","volume":"247","author":"Hoffman","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0600","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/hmg\/7.9.1507","article-title":"5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease","volume":"7","author":"Holmes","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0605","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0922-4106(93)90128-V","article-title":"Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit","volume":"245","author":"Hope","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0610","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","article-title":"International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0615","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0620","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/syn.890140410","article-title":"Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study","volume":"14","author":"Hrdina","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0625","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(93)91015-K","article-title":"5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims\/depressives: increase in 5-HT2 sites in cortex and amygdala","volume":"614","author":"Hrdina","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0630","article-title":"Amisulpride and symptomatic bradycardia: a case report","author":"Huang","year":"2013","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0635","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1992.01820090067011","article-title":"Toward a neuroanatomy of obsessive\u2013compulsive disorder","volume":"49","author":"Insel","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0640","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.neuroscience.2006.11.004","article-title":"Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study","volume":"144","author":"Invernizzi","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0645","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.mp.4001437","article-title":"Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders","volume":"9","author":"Iwamoto","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0650","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-2999(93)90453-O","article-title":"Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs","volume":"231","author":"Jenck","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0655","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0278-5846(94)90013-2","article-title":"Brain 5-HT1C receptors and antidepressants","volume":"18","author":"Jenck","year":"1994","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0660","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1517\/13543784.7.10.1587","article-title":"The role of 5-HT2C receptors in affective disorders","volume":"7","author":"Jenck","year":"1998","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0665","first-page":"487","article-title":"Obsessive\u2013compulsive disorder: efficacy of specific treatments as assessed by controlled trials","volume":"29","author":"Jenike","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0670","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0006-3223(94)91236-X","article-title":"Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine","volume":"35","author":"Kahn","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0675","series-title":"Principles of Neural Science","first-page":"1209","article-title":"Depression, mania and anxiety disorders","author":"Kandel","year":"2001"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0680","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/JCP.0b013e318169cca7","article-title":"Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia","volume":"28","author":"Kane","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0685","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1471-4159.1995.64010199.x","article-title":"Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus","volume":"64","author":"Kaufman","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0690","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(01)02091-1","article-title":"Serotonin, excitatory amino acids and the photic control of melatonin rhythms and SCN c-FOS in the rat","volume":"897","author":"Kennaway","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0695","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/11534420-000000000-00000","article-title":"Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness","volume":"24","author":"Kennedy","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0700","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1476-5381.1994.tb14808.x","article-title":"In vivo properties of SB 200646A, a 5-HT2C\/2B receptor antagonist","volume":"111","author":"Kennett","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0705","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF02245837","article-title":"Effect of SB 200646A, a 5-HT2C\/5-HT2B receptor antagonist, in two conflict models of anxiety","volume":"118","author":"Kennett","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0710","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1476-5381.1996.tb15304.x","article-title":"Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety","volume":"117","author":"Kennett","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0715","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1476-5381.1996.tb15208.x","article-title":"In vitro and in vivo profile of SB 206553, a potent 5-HT2C\/5-HT2B receptor antagonist with anxiolytic-like properties","volume":"117","author":"Kennett","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0720","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-5728(99)00101-0","article-title":"5-HT3 receptor-channels coupled with Na+ influx in human T cells: role in T cell activation","volume":"99","author":"Khan","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0725","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1460-9568.2009.06831.x","article-title":"Overexpression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity","volume":"30","author":"Kimura","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0730","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.1118265","article-title":"The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C","volume":"311","author":"Kishore","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0735","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/syn.890010204","article-title":"The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei","volume":"1","author":"Kosofsky","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0740","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0014-2999(94)90086-8","article-title":"5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine","volume":"255","author":"Kuoppamaki","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0745","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0893-133X(95)00049-J","article-title":"Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs","volume":"13","author":"Kuoppamaki","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2015.12.006_bb0750","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.yic.0000195658.91524.61","article-title":"Sleep disturbances and depression: a challenge for antidepressants","volume":"21","author":"Lam","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0755","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.mp.4000883","article-title":"Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder","volume":"6","author":"Lerer","year":"2001","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0760","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0765","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1568007043482598","article-title":"5-HT2 receptors","volume":"3","author":"Leysen","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0770","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cne.11004","article-title":"Unique expression patterns of 5-HT2A and 5-HT2C receptors in the rat brain during postnatal development: Western blot and immunohistochemical analyses","volume":"469","author":"Li","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0775","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuropharm.2011.09.002","article-title":"Anxiolytic effects of 5-HT(1)A receptors and anxiogenic effects of 5-HT(2)C receptors in the amygdala of mice","volume":"62","author":"Li","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0780","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/sj.bjp.0704809","article-title":"Differential coupling of 5-HT(1) receptors to G proteins of the G(i) family","volume":"136","author":"Lin","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0785","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.neuroscience.2007.02.064","article-title":"Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction","volume":"146","author":"Liu","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0790","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004850-200209000-00004","article-title":"Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study","volume":"17","author":"Loo","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0795","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/syn.1095","article-title":"Regional distribution and cellular localization of 5-HT2C receptor mRNA in monkey brain: comparison with [3H]mesulergine binding sites and choline acetyltransferase mRNA","volume":"42","author":"Lopez-Gimenez","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0800","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nrn1220","article-title":"Neurobiology of suicidal behaviour","volume":"4","author":"Mann","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0805","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1192\/S000712500029171X","article-title":"Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies","author":"Mann","year":"1989","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0810","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1176\/ajp.156.2.181","article-title":"Toward a clinical model of suicidal behavior in psychiatric patients","volume":"156","author":"Mann","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0815","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1074\/jbc.M308742200","article-title":"RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms","volume":"279","author":"Marion","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0820","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/jpet.106.106989","article-title":"WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor\u2013selective agonist with preclinical antipsychotic-like activity","volume":"320","author":"Marquis","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0825","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0091-3057(01)00713-4","article-title":"Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety","volume":"71","author":"Martin","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0830","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0893-133X(98)00007-4","article-title":"Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients","volume":"19","author":"Masellis","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0835","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1124\/mol.62.6.1339","article-title":"Phospholipase D activation by endogenous 5-hydroxytryptamine 2C receptors is mediated by Galpha13 and pertussis toxin-insensitive Gbetagamma subunits","volume":"62","author":"McGrew","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0840","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-0327(87)90075-9","article-title":"5-HT receptor binding in post-mortem brain from patients with affective disorder","volume":"13","author":"McKeith","year":"1987","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0845","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1176\/ajp.152.6.821","article-title":"Clozapine: is another view valid?","volume":"152","author":"Meltzer","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0850","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/schbul\/2.1.19","article-title":"The dopamine hypothesis of schizophrenia: a review","volume":"2","author":"Meltzer","year":"1976","journal-title":"Schizophr. Bull."},{"issue":"99 Suppl.","key":"10.1016\/j.pnpbp.2015.12.006_bb0855","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1007\/BF00442563","article-title":"A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report","author":"Meltzer","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0860","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.nlm.2006.12.005","article-title":"Do serotonin(1\u20137) receptors modulate short and long-term memory?","volume":"87","author":"Meneses","year":"2007","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0865","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbr.2007.06.026","article-title":"Stimulation of 5-HT1A, 5-HT1B, 5-HT2A\/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory","volume":"184","author":"Meneses","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0870","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0024-3205(84)90334-5","article-title":"Reduction of serotonin-2 receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof","volume":"34","author":"Mikuni","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0875","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/1.9.681","article-title":"Serotonin receptor 1c gene assigned to X chromosome in human (band q24) and mouse (bands D-F4)","volume":"1","author":"Milatovich","year":"1992","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0880","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2515\/therapie:2005065","article-title":"Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies","volume":"60","author":"Millan","year":"2005","journal-title":"Therapie"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0885","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0890","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0028-3908(98)00078-1","article-title":"Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo","volume":"37","author":"Millan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0895","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1460-9568.2000.00982.x","article-title":"Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram","volume":"12","author":"Millan","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0900","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/026988110001400202","article-title":"Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents","volume":"14","author":"Millan","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0905","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.103.051797","article-title":"The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways","volume":"306","author":"Millan","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0910","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.neuro.24.1.167","article-title":"An integrative theory of prefrontal cortex function","volume":"24","author":"Miller","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0915","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajmg.b.30115","article-title":"Clozapine-induced weight gain associated with the 5HT2C receptor -759C\/T polymorphism","volume":"133B","author":"Miller","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0920","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-6147(00)88963-4","article-title":"Inverse agonism: pharmacological curiosity or potential therapeutic strategy?","volume":"16","author":"Milligan","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0925","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","article-title":"Serotonin: a review","volume":"31","author":"Mohammad-Zadeh","year":"2008","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0930","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.neuropharm.2010.06.009","article-title":"Functional relevance of serotonin 2C receptor mRNA editing in antidepressant- and anxiety-like behaviors","volume":"59","author":"Mombereau","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0935","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1600-0447.1994.tb01538.x","article-title":"Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive\u2013compulsive disorder","volume":"89","author":"Monteleone","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0940","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0924-977X(93)90266-O","article-title":"A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive\u2013compulsive disorder. The Lilly European OCD Study Group","volume":"3","author":"Montgomery","year":"1993","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0945","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2010.04.004","article-title":"Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader\u2013Willi syndrome","volume":"39","author":"Morabito","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0950","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF02246963","article-title":"Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats","volume":"110","author":"Moreau","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0955","first-page":"51","article-title":"Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression","volume":"19","author":"Moreau","year":"1994","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0960","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0924-977X(96)00015-6","article-title":"5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats","volume":"6","author":"Moreau","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0965","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12024-013-9410-1","article-title":"Lethal neuroleptic malignant syndrome due to amisulpride","volume":"9","author":"Musshoff","year":"2013","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0970","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.biopsych.2005.07.035","article-title":"Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo","volume":"59","author":"Navailles","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0975","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1471-4159.2006.04188.x","article-title":"Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors","volume":"99","author":"Navailles","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0980","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1568007043482606","article-title":"5-HT5 receptors","volume":"3","author":"Nelson","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"issue":"Suppl. 4","key":"10.1016\/j.pnpbp.2015.12.006_bb0985","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0990","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1073\/pnas.94.5.2036","article-title":"Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac)","volume":"94","author":"Ni","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb0995","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ddr.20016","article-title":"5-HT2 receptors and anxiety","volume":"65","author":"Nic","year":"2005","journal-title":"Drug Dev. Res."},{"issue":"Suppl. 22","key":"10.1016\/j.pnpbp.2015.12.006_bb1000","first-page":"12","article-title":"The functional anatomy, neurochemistry, and pharmacology of anxiety","volume":"60","author":"Ninan","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1176\/ajp.141.4.566","article-title":"CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients","volume":"141","author":"Ninan","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.1998.tb10171.x","article-title":"Identification and characterization of RNA editing events within the 5-HT2C receptor","volume":"861","author":"Niswender","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1015","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0893-133X(00)00223-2","article-title":"RNA editing of the human serotonin 5-HT2C receptor. Alterations in suicide and implications for serotonergic pharmacotherapy","volume":"24","author":"Niswender","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0306-4522(01)00593-0","article-title":"Localization of 5-HT(2A) receptors on dopamine cells in subnuclei of the midbrain A10 cell group","volume":"111","author":"Nocjar","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroscience.2015.03.050","article-title":"Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex","volume":"297","author":"Nocjar","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1030","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/2647","article-title":"Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene","volume":"4","author":"Nonogaki","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1035","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1176\/ajp.152.10.1444","article-title":"D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients","volume":"152","author":"Nordstrom","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1040","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archpsyc.1993.01820200046005","article-title":"Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia","volume":"50","author":"Owen","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1045","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF02246453","article-title":"Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor","volume":"126","author":"Palvimaki","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/PL00022053","article-title":"Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide","volume":"31","author":"Pandey","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1060","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0306-4522(99)00011-1","article-title":"Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain","volume":"92","author":"Pasqualetti","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0014-2999(84)90057-8","article-title":"The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site","volume":"106","author":"Pazos","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1070","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1176\/appi.ajp.158.7.1105","article-title":"Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia","volume":"158","author":"Perlstein","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.7221567","article-title":"Two distinct central serotonin receptors with different physiological functions","volume":"212","author":"Peroutka","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/mol.61.1.85","article-title":"Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai\/o-proteins","volume":"61","author":"Pindon","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-3223(89)90022-X","article-title":"Animal models of compulsive behavior","volume":"26","author":"Pitman","year":"1989","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0169-328X(94)90223-2","article-title":"Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors","volume":"23","author":"Pompeiano","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1471-4159.2002.00947.x","article-title":"Stimulation of 5-hydroxytryptamine (5-HT(2C)) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex","volume":"82","author":"Pozzi","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1100","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0026-895X(24)23120-5","article-title":"RNA editing of the human serotonin 5-HT(2C) receptor delays agonist-stimulated calcium release","volume":"58","author":"Price","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1105","doi-asserted-by":"crossref","first-page":"44663","DOI":"10.1074\/jbc.M106745200","article-title":"RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein","volume":"276","author":"Price","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1110","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/j.1476-5381.1995.tb16684.x","article-title":"Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area","volume":"116","author":"Prisco","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3109\/15622975.2011.595823","article-title":"Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors","volume":"12","author":"Racagni","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/alzrt169","article-title":"5-HT6 receptors and Alzheimer's disease","volume":"5","author":"Ramirez","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1125","series-title":"Serotonin Receptors in Neurobiology. Boca Raton (FL)","article-title":"Serotonin 2A (5-HT2A) Receptor Function: Ligand-dependent Mechanisms and Pathways","author":"Raote","year":"2007"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3565(24)29304-6","article-title":"Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor","volume":"299","author":"Rauser","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1135","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.bjp.0702350","article-title":"Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist","volume":"126","author":"Reavill","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(97)00115-5","article-title":"Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test","volume":"325","author":"Redrobe","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.0065-1591.2000.007s021[dash]5.x","article-title":"Safety profile of amisulpride in short- and long-term use","volume":"400","author":"Rein","year":"2000","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1150","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.pnpbp.2005.03.019","article-title":"The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment","volume":"29","author":"Reynolds","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1359786806066040","article-title":"The 5-HT2C receptor and antipsychoticinduced weight gain \u2014 mechanisms and genetics","volume":"20","author":"Reynolds","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1160","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1097\/00001756-199705260-00040","article-title":"Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor","volume":"8","author":"Rietschel","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/tpj.2010.66","article-title":"Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study","volume":"12","author":"Risselada","year":"2012","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1170","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/sj.npp.1301636","article-title":"Opposing roles for 5-HT2A and 5-HT2C receptors in the nucleus accumbens on inhibitory response control in the 5-choice serial reaction time task","volume":"33","author":"Robinson","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1175","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1523\/JNEUROSCI.22-22-10039.2002","article-title":"Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice","volume":"22","author":"Rocha","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1180","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1358\/dnp.2007.20.9.1162244","article-title":"5-HT2C receptor agonists as an innovative approach for psychiatric disorders","volume":"20","author":"Rosenzweig-Lipson","year":"2007","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1185","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0022-3565(25)11452-3","article-title":"Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors","volume":"260","author":"Roth","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1586\/ecp.10.139","article-title":"Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review","volume":"4","author":"Sacchetti","year":"2011","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1195","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02245655","article-title":"Reversal of antidepressant action by dopamine antagonists in an animal model of depression","volume":"104","author":"Sampson","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ddr.430220306","article-title":"Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound","volume":"22","author":"Sanchez","year":"1991","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1205","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/mi.3.6.319","article-title":"Serotonin 5-ht2 receptors: molecular and genomic diversity","volume":"3","author":"Sanders-Bush","year":"2003","journal-title":"Mol. Interv."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1210","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008877-200006000-00008","article-title":"Pharmacological and molecular targets in the search for novel antipsychotics","volume":"11","author":"Scatton","year":"2000","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1215","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00041444-199722000-00003","article-title":"Schizophrenia, chronic hospitalization and the 5-HT2C receptor gene","volume":"7","author":"Segman","year":"1997","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728222.8.1.15","article-title":"The 5-HT2C receptor as a target for mood disorders","volume":"8","author":"Serretti","year":"2004","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-2396(199709)27:1<45::AID-SYN5>3.0.CO;2-D","article-title":"Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: effect of 5,7-dihydroxytryptamine","volume":"27","author":"Sharma","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.npp.1300591","article-title":"The effect of clozapine on extracellular dopamine levels in the shell subregion of the rat nucleus accumbens is reversed following chronic administration: comparison with a selective 5-HT(2C) receptor antagonist","volume":"30","author":"Shilliam","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1240","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuropharm.2006.07.024","article-title":"CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity","volume":"52","author":"Siuciak","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1245","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/oby.2008.537","article-title":"Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women","volume":"17","author":"Smith","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00001756-199512000-00041","article-title":"Association between clozapine response and allelic variation in the 5-HT2C receptor gene","volume":"7","author":"Sodhi","year":"1995","journal-title":"Neuroreport"},{"issue":"Suppl. 19","key":"10.1016\/j.pnpbp.2015.12.006_bb1255","first-page":"6","article-title":"The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice","volume":"64","author":"Stahl","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1260","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.2174\/1381612821666150605111236","article-title":"Atypical antipsychotics and inverse agonism at 5-HT2 receptors","volume":"21","author":"Sullivan","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1265","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244785","article-title":"Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?","volume":"115","author":"Tanda","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF02246169","article-title":"Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat","volume":"123","author":"Tanda","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1275","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/374542a0","article-title":"Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors","volume":"374","author":"Tecott","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1280","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.1073\/pnas.95.25.15026","article-title":"Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice","volume":"95","author":"Tecott","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1285","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00213-005-2268-5","article-title":"SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit","volume":"181","author":"Terranova","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1290","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.psychres.2009.03.020","article-title":"Absence of weight gain association with the HTR2C -759C\/T polymorphism in patients with schizophrenia treated with iloperidone","volume":"175","author":"Thompson","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1295","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0006-3223(01)01207-0","article-title":"Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive\u2013compulsive disorder","volume":"51","author":"Tizabi","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1300","first-page":"291","article-title":"Transgenic approaches to epilepsy","volume":"79","author":"Toth","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00023210-200923060-00003","article-title":"Neuroleptic malignant syndrome associated with atypical antipsychotic drugs","volume":"23","author":"Trollor","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1310","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.cortex.2012.10.014","article-title":"Are core component processes of executive function dissociable within the frontal lobes? Evidence from humans with focal prefrontal damage","volume":"49","author":"Tsuchida","year":"2013","journal-title":"Cortex"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1315","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4088\/JCP.v66n1008","article-title":"Sleep and depression","volume":"66","author":"Tsuno","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1320","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1152\/ajplegacy.1953.175.1.157","article-title":"Serotonin content of some mammalian tissues and urine and a method for its determination","volume":"175","author":"Twarog","year":"1953","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1325","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s007260070051","article-title":"The medial prefrontal cortex as a part of the brain reward system","volume":"19","author":"Tzschentke","year":"2000","journal-title":"Amino Acids"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1330","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0006-8993(93)90077-Z","article-title":"Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens","volume":"624","author":"Van Bockstaele","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1335","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1353\/pbm.1986.0033","article-title":"Depression: a disorder of timekeeping?","volume":"29","author":"Van Cauter","year":"1986","journal-title":"Perspect. Biol. Med."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1340","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/S0024-3205(03)00141-3","article-title":"5-HT2A and 5-HT2C receptors and their atypical regulation properties","volume":"72","author":"Van Oekelen","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1345","first-page":"377","article-title":"Serotonin receptor ligands and the treatment of obesity","volume":"5","author":"Vickers","year":"2004","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1350","first-page":"131","article-title":"Relevance of serotonergic postmortem studies to suicidal behaviour","volume":"4","author":"Victoria Arango","year":"1992"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1355","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/protein\/14.6.409","article-title":"Differences in conformational properties of the second intracellular loop (IL2) in 5HT(2C) receptors modified by RNA editing can account for G protein coupling efficiency","volume":"14","author":"Visiers","year":"2001","journal-title":"Protein Eng."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1360","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-9964(95)00013-C","article-title":"Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground","volume":"16","author":"Weinberger","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1365","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pharmthera.2008.03.012","article-title":"RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function","volume":"119","author":"Werry","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-1781(96)02001-X","article-title":"Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine","volume":"64","author":"Wetzler","year":"1996","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1375","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1038\/sj.npp.1395355","article-title":"The discovery of serotonin and its role in neuroscience","volume":"21","author":"Whitaker-Azmitia","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1380","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pscychresns.2004.07.001","article-title":"A meta-analysis of functional neuroimaging in obsessive\u2013compulsive disorder","volume":"132","author":"Whiteside","year":"2004","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1385","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(97)01267-5","article-title":"Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens","volume":"781","author":"Willins","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1390","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0306-4522(98)00653-8","article-title":"Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo","volume":"91","author":"Willins","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1395","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/endo.141.2.7311","article-title":"Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat","volume":"141","author":"Wolden-Hanson","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1400","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1073\/pnas.40.4.228","article-title":"A biochemical and pharmacological suggestion about certain mental disorders","volume":"40","author":"Woolley","year":"1954","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1405","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1006\/geno.1996.0397","article-title":"The human serotonin 5-HT2C receptor: complete cDNA, genomic structure, and alternatively spliced variant","volume":"35","author":"Xie","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1410","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0893-133X(98)00082-7","article-title":"Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus","volume":"20","author":"Youngren","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1415","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2004.12.014","article-title":"Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression","volume":"45","author":"Zhang","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2015.12.006_bb1420","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cmet.2007.10.008","article-title":"Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways","volume":"6","author":"Zhou","year":"2007","journal-title":"Cell Metab."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584615300713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584615300713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:46:40Z","timestamp":1759520800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584615300713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":283,"alternative-id":["S0278584615300713"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.12.006","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-HT2C receptors in psychiatric disorders: A review","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}